Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PDIA6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HLA-DPA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CSNK2A1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MST1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MRPL33 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
CFLAR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BRF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BLZF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARPIN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARPC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NPTN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DTNA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DSE - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PSMC6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HEMK1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SARAF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LRP4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KLK13 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IKBKG - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on